Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Pathophysiology of Renal Disease and Progression
You have accessRestricted Access

Evidence of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model

Krissanapong Manotham, Tetsuhiro Tanaka, Makiko Matsumoto, Takamoto Ohse, Toshio Miyata, Reiko Inagi, Kiyoshi Kurokawa, Toshiro Fujita and Masaomi Nangaku
JASN May 2004, 15 (5) 1277-1288; DOI: https://doi.org/10.1097/01.ASN.0000125614.35046.10
Krissanapong Manotham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuhiro Tanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makiko Matsumoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takamoto Ohse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshio Miyata
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reiko Inagi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiyoshi Kurokawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiro Fujita
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaomi Nangaku
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

ABSTRACT. The remnant kidney model is a mainstay in the study of progressive renal disease. The earliest changes in this model result from glomerular hemodynamic alterations. Given that progressive renal disease is the result of subsequent interstitial damage initiated by undetermined pathogenic factors, the authors investigated the role of hypoxia as a pathogenic factor in tubulointerstitial damage after renal ablation in rats. Cortical tissue hypoxia in the early phase (4 and 7 d) in remnant kidney rats, sham-operated rats, and animals treated with the angiotensin II receptor blocker (ARB) olmesartan (10 mg/kg per d) was assessed by uptake of a hypoxic probe, pimonidazole, expression of HIF-1α, and by increased transcription of hypoxia-responsive genes. Physiologic perfusion status of the postglomerular peritubular capillary network was evaluated by lectin perfusion and Hoechst 33342 diffusion techniques. Results showed that the number of hypoxic tubules was markedly increased 4 and 7 d after nephron loss. These findings antedated any histologic evidence of tubulointerstitial damage. The hypoxic state persisted until interstitial damage developed. These results were confirmed using HIF-1α immunoprecipitation and increase of hypoxia-responsive genes. Pathologic studies of the vasculature demonstrated significant functional changes that generated a hypoxic milieu. ARB treatment prevented vascular changes and ameliorated tubular hypoxia. These results suggest that the initial tubulointerstitial hypoxia in remnant kidney model plays a pathogenic role in the subsequent development of tubulointerstitial injury. The initial hypoxia in this model was dependent on activation of the renin-angiotensin system and hemodynamic alterations after nephron loss.

The remnant kidney is a representative model in the study of progressive renal disease. The earliest response in this model consists of intrarenal vasodilation with relatively poor dilation of efferent arterioles, which in turn generates glomerular hyperfiltration and hypertension (1). Glomerular hyperfiltration, which depends on activation of the renin-angiotensin system (RAS), eventually leads to glomerulosclerosis (1). However, the deterioration of renal function is well correlated with the progressive interstitial damage, which evolves in the late phase, rather than glomerular lesions (2–4⇓⇓), and the mechanism(s) that initiate(s) tubulointerstitial injury in the context of early hemodynamic alterations remain(s) to be elucidated.

Chronic tissue hypoxia is regarded as a contributing factor in the progression of renal failure (5). Loss of peritubular capillaries in the late phase of various disease models has been recently reported (6–11⇓⇓⇓⇓⇓), giving indirect evidence of renal hypoxia. Hypoxia itself can initiate the inflammatory process and eventually lead to tissue fibrosis (12–17⇓⇓⇓⇓⇓). In a remnant kidney model, Kang et al. (11) reported that the loss of peritubular capillaries occurred around the second week, at which time severe tubulointerstitial injury started to develop. Prevention of this loss by VEGF administration abolished subsequent tubulointerstitial damage. These data strongly support the notion that hypoxia might be a cause, rather than an epiphenomenon, of tubulointerstitial damage. However, evidence of hypoxia in the early phase of this representative model before the development of histologic damage remains to be clarified. We have investigated the hypothesis that hemodynamic alterations might lead to tubulointerstitial hypoxia in the very early phase in this model, which might in turn induce tubulointerstitial damage and lead to eventual kidney failure.

To prove this hypothesis, we designed the current study to look for evidence of hypoxia within the first week after renal mass reduction. At this time point, hemodynamic alterations are well established but tubulointerstitial damage is negligible (18). Here, findings showed that many tubules suffer from hypoxic conditions in the early phase of remnant kidney. Furthermore, hypoxia in the tubulointerstitial compartment preceded traditional evidence of tubulointerstitial damage and persisted until the damage developed. Investigations utilizing angiotensin II receptor blockage (ARB) suggested that the tubular hypoxia was dependent on the activation of RAS.

Materials and Methods

Animals

Male Sprague-Dawley rats weighing 260 to 280 g were purchased from Nippon Seibutsu Zairyo Center Co. (Saitama, Japan). They were housed in an animal room maintained at a constant temperature with a 12-h light-dark cycle with free access to water and standard diet. When urine was collected, rats were housed in metabolic cages under the same conditions. BP was measured under conscious conditions using the volume-oscillometric method (Ueda, Tokyo, Japan). All studies conformed to the principles of the Guide for Animal Experimentation at the University of Tokyo.

Antibodies

Monoclonal mouse anti-human α-smooth muscle actin (α-SMA) 1:1000 (Boehringer Mannheim, Mannheim, Germany), mouse antipimonidazole 1:200 (Chemicon, Temecula, CA), mouse anti-rat vimentin 1:1000 (Dako, Glostrup, Denmark), biotinylated anti-mouse Ig 1:400 (Vector Laboratories, Burlingame, CA), and alkaline phosphatase-conjugated anti-mouse IgG 1:1000 (Promega, Madison, WI) were used in immunohistochemical studies. Monoclonal mouse anti-human HIF-1α 1:1000 (Novus Biologic, Littleton, CO) was used in immunoprecipitation studies.

Disease Model and Experimental Protocol

Eight rats served as a sham-operated control (sham group), and 36 underwent 5/6 nephrectomy as described previously (19). In brief, after right subcapsular nephrectomy, infarction of approximately two thirds of the left kidney was accomplished by ligation of the posterior and one or two anterior extrarenal branches of the main left renal artery. Sixteen of these animals received an ARB, olmesartan (Pharmacology and Molecular Biology Research Laboratories, Sankyo Pharmaceutical, Tokyo, Japan), at a dosage of 10 mg/kg per d (20) by gastric gavage (RK+ARB group). The remaining animals were not treated with this reagent (RK group, n = 20). Treatment was started the day after operation and continued until the day of sacrifice. Eight rats each from the RK and RK+ARB groups were sacrificed at 4 and 7 d (early phase) after the operation and designated as the 4d RK, 7d RK, 4d RK+ARB, and 7d RK+ARB groups, respectively. Sham animals were sacrificed on day 7. The four remaining rats in the RK group were killed at 2 wk to examine the persistence of findings (extended RK). Twenty-four-hour urine and tail vein blood were collected before sacrifice. To detect hypoxia, 60 mg/kg of hypoxic probe, pimonidazole (Chemicon), was injected intraperitoneally 2 h before sacrifice (21–23⇓⇓). To demonstrate functioning vessels, 250 μg of biotinylated lectin (Lycopersicon esculentum Lectin, Vector Laboratories) was injected via the tail vein exactly 4 min before sacrifice (24). To study the tissue perfusion properties of each vessel, 15 mg/kg of bisbezamine (Hoechst 33342; Sigma Chemical, St. Louis, MO) was injected via the inferior vena cava just below the left renal vein. Exactly 30 sec after injection, the renal pedicle was clamped and the kidney was promptly removed (25). To maintain the most representative perfusion patterns of vessels, all materials were intentionally injected without the use of a pressure pump. Kidney tissues for analysis were carefully selected to exclude necrotic areas. One sample of kidney tissue was fixed in methyl Carnoy’s fixative and then embedded in paraffin. All specimens were stored in light-protected containers. A second piece of the kidney was dissected in ice-cold PBS, and the medulla was removed, which was then snap-frozen in liquid nitrogen before transfer to storage at −80°C until further analysis.

To validate our methodology of Hoechst dye perfusion, 12 additional rats were studied as described below in Nuclear Fluorescence Studies of Tissue Perfusion Properties of this section. Three of these animals underwent renal artery stenosis according to a model described previously (17), three underwent 6-wk 5/6 nephrectomy, three served as a sham-operated control, and three were examined without administration of the Hoechst dye.

Double and Triple Immunohistochemical Analysis

Immunohistochemical staining was performed as described previously (26). Avidin HRP was used to stain biotinylated lectin-perfused vessels. Chromogenic color was developed with 3,3′diaminobenzidine tetrahydrochloride (DAB). After staining the first antigen, the remaining peroxidase activity was extinguished with 3% H2O2 in methanol for 10 min. The remaining biotin was blocked by incubation with avidin solution (Vector Laboratories), after which the first antibodies for the second antigen were applied, followed by suitable secondary antibodies (biotinylated or alkaline phosphatase-conjugated). Color was developed with DAB plus 0.8% nickel or Vector Red (Vector Laboratories). When alkaline phosphatase reaction was used, endogenous alkaline phosphatase was blocked with levamisole solution (Vector Laboratories). The processes were repeated for the third antigen staining. Negative controls without first antibodies were carefully examined for each reaction. All histologic slides were examined by light microscopy using an Olympus BX51 (Tokyo, Japan), and pictures were taken with the Olympus DP12 system. In some experiments, nuclei were counter-stained with methyl green (Vector Laboratories).

Nuclear Fluorescence Studies of Hoechst Dye to Investigate Tissue Perfusion Properties

For indirect comparison of tissue perfusion properties of Hoechst dye, 4-μm sections of paraffin-embedded tissues were stepwise rehydrated in a light-protected container. Rehydrated tissues were mounted and immediately photographed at 600× magnification (Eclipse E600, Nikon, Tokyo, Japan; connected to a cool charge-couple device [CCD], Micromax, Princeton Instruments, Trenton, NJ, and Metamorph, Downingtown, PA) avoiding any part of the glomeruli. In this step, the exposure time was fixed at 50 msec and the CCD temperature was set below −10°C.

Semiquantitative Scoring System

All scoring was done in a blinded manner. Photographs were examined in gray scale. Tubulointerstitial injuries in the cortex were scored in a blinded manner on 20 randomly selected non-overlapping 200× fields per rat on periodic acid-Schiff (PAS) and Trichrome Masson staining sections as described previously (11). Semiquantitative scores for pimonidazole adduction, α-SMA expression, and tubular vimentin expression were evaluated from 20 nonoverlapping fields at 200× magnification from each rat according to the following scoring method: 0, no involvement; 1, involvement of <10% of the cortex; 2, involvement of 10% to 25% of the cortex; 3, involvement of 26% to 50% of the cortex; 4, involvement of 51% to 75% of the cortex; and 5, involvement of >75% of the cortex.

The amount of postglomerular peritubular capillaries was evaluated by the vascular rarefaction index and the number of capillary lumina per 100 tubules by detection of perfused lectin as described previously (7,11⇓). Measurement of capillary luminal areas was done using 10 randomly selected 400× pictures per rat (334.2 ± 55 lumina/animal) in a blinded manner with the Image J software (http://rsb.info.nih.gov/ij/).

Perfusion status with the nucleus-staining Hoechst dye was evaluated using Photoshop, version 7.0 (Adobe, San Jose, CA), as follows. Pictures were normalized by decreasing background signals of autofluorescence of tubular cell cytoplasm to undetectable levels (27,28⇓). Nuclei were selected with the Wand tool of Photoshop, which automatically selects areas of nuclei. A mean log scale of luminosity of selected areas from each picture was then measured by the histogram function. Our preliminary studies of a renal artery stenosis model (n = 3) showed almost undetectable parenchymal nuclear fluorescence. Mean nuclear luminosity of 6-wk remnant kidney animals (n = 3) was 63 ± 8.6. Nuclear luminosity of sham-operated animals (n = 3) by this method was 121.9 ± 4.3, and background luminosity of non-injected animals (n = 3) was 0.34 ± 0.2.

Proliferation of endothelial cells was evaluated on double-staining of perfused lectin and PCNA by counting PCNA-positive nuclei per thousand visualized cortical capillary lumina from each rat.

Immunoprecipitation of HIF-1α

To confirm that remnant kidneys were hypoxic, 20 mg of protein of homogenized cortical tissues of each animal was subjected to protein A Sepharose immunoprecipitation (Amersham International, Buckingham, UK) according to the manufacturer’s protocol (29). The precipitated protein was separated by electrophoresis in 8% SDS-PAGE gel or 4 to 20% SDS-PAGE gradient gel (Diaichi Pure Chemical, Tokyo, Japan), followed by electrotransfer to PVDF membranes (Amersham International). Transfer membranes were blocked with 5% nonfat milk in TBS, 0.01% Tween-20, for 30 min at room temperature. The membranes were then blotted with anti-HIF1α antibody (Novus Biologic) at 1:100 at room temperature for 2 h. The bound antibodies were detected with alkaline phosphatase-conjugated secondary antibodies. 5-Bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablets (Sigma Fast; Sigma Chemical) were used as a chromogenic substrate.

Total RNA Isolation and Real-Time RT-PCR

Total RNA from cortical tissues from each rat was isolated with Isogen according to the manufacturer’s protocol (Wako Chemical, Osaka, Japan). cDNA synthesis was carried out with 2 μg of isolated RNA at 42°C for 1 h with an oligoDT Inpromp-II kit (Promega). One microgram of cDNA was subjected to real-time PCR (iCycler iQ; Bio-Rad, Hercules, CA) utilizing Syber Green Supermix (Bio-Rad) with the correspondence primers as follows: β-actin: 5′-CTTTCTACAATGAGCTGCGTG-3′, 5′-TCATGAGGTAGTCTGTCAGG-3′; erythropoietin (EPO): 5′-TACGTAGCCTCACTTCACTGCTT-3′, 5′-GCAGAAAGTATCCGCTGTGAGTGTTC-3′; Glucose transporter-1 (GLUT-1): 5′-CAGTTCGGCTATAACACCGGTGTC-3′, 5′-ATAGCGGTGGTTCCATGTTT-3′; and vascular endothelial growth factor (VEGF): 5′-TTACTGCTGTACCTCCAC-3′, 5′-ACAGGACGGCTTGAAGATA-3′ (30). The PCR was amplified for forty cycles. Each PCR product was subjected to melting curve analysis after PCR was completed. Threshold cycles for each primer were separately analyzed. The amount of target mRNA/β-actin mRNA were calculated according to the following equation: target mRNA/β-actin mRNA = 2−(tc − bc) where tc and bc are threshold cycles of the target gene and β-actin, respectively. Representative data are presented in terms of fold mRNA changes compared with sham.

Statistical Analyses

All numerical data are presented as mean ± SD. Distributions of some data are shown by histogram. One-way ANOVA followed by the least significant difference (LSD) method was used to determine differences among groups for all continuous parameters. The Mann-Whitney test was applied for noncontinuous parameters. Correlations between two parameters were analyzed with Pearson correlation test. The significance level was set at P < 0.05 for all tests (SPSS for Windows 10.0).

Results

Absence of Histologic Interstitial Injury in the Early Phase in the Remnant Kidney Model

Remnant kidney animals (RK) showed a significant increase in urinary protein excretion, at 34.2 ± 8.7 and 51.5 ± 8.6 mg/d in the 4d RK and 7d RK rats, respectively, compared with 8.2 ± 0.5 mg/d in the control rats. ARB decreased urinary protein excretion to 20.3 ± 3.7 and 20.3 ± 4.5 mg/d in the 4d RK+ARB and 7d RK+ARB rats, respectively (P < 0.05 versus RK). BUN concentrations were 16.1 ± 1.2, 32.8 ± 9.1, 36.5 ± 11.7.4, and 62.5 ± 6.7 mg/dl for sham, 4d RK, 7d RK, and Extended RK animals, respectively. BP was higher in RK animals than in the control. ARB treatment significantly decreased BP (Table 1).

View this table:
  • View inline
  • View popup

Table 1. Basic biological data

Examination of PAS and Trichrome Masson samples in the early phase of remnant kidneys, at 4 and 7 d after operation, showed hypertrophic glomeruli and tubules. No significant interstitial changes were seen at this time point (Figure 1, a and e, b and f). In contrast, rats sacrificed at 2 wk showed some atrophic tubular cells, thickening of tubular basement membrane, and mild interstitial expansion (data not shown). Interstitial damage scores did not differ between sham and early RK groups (Table 2). The extended RK group had a higher interstitial damage score, although damage in this group was not prominent even at this time point. In the ARB-treated group, glomerular hypertrophy was less prominent.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Histologic and immunohistochemical analysis of remnant kidneys in the early phase. Periodic acid-Schiff (PAS) and Trichrome Masson staining of normal kidneys (sham group) showed no evidence of tubulointerstitial damage (a and b). PAS and Trichrome Masson staining of the early phase of remnant kidneys (7d RK) (e and f) also showed no interstitial damage. Double-staining with perfused lectin (brown) and vimentin (black) showed that expression of vimentin in tubules could not be detected in either sham (c) or 7d RK (g). Immunohistochemical studies of α-smooth muscle actin (α-SMA) showed lack of interstitial myofibroblasts in sham (d) and 7d RK (h).

View this table:
  • View inline
  • View popup

Table 2. Semiquantitative scores of histological analysis

Development of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model

In the sham group, pimonidazole, which serves as an indicator of hypoxic cells (21–23⇓⇓), was detected in medullary tubules (Figure 2, a and d), which as previously reported are normally in a state of borderline hypoxia (22,23⇓). The number of pimonidazole-positive tubules in the cortex was markedly increased at 4 and 7 d after nephron loss (Figure 2, b and e). Semiquantitative scores of cortical pimonidazole uptake were 2.6 ± 0.4 and 3.1 ± 0.3 for 4d RK and 7d RK, respectively, while that of the control was 0.6 ± 0.2 (P < 0.05). Pimonidazole staining intensity was still high in the cortex in the extended phase at 2 wk after the renal mass reduction (Figure 2c). ARB treatment decreased the pimonidazole-positive score to 0.9 ± 0.3 and 1.4 ± 0.6 at 4 and 7 d, respectively (Figure 2b).

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Increased pimonidazole uptake by remnant kidneys in the early phase. Double immunohistochemical staining with perfused lectin (brown) and a hypoxic probe, pimonidazole (gray) (×200). (a) No pimonidazole uptake was observed in the renal cortex in the sham group, while tubules in the deep medulla were pimonidazole-positive. (b) In the early phase after nephron loss (4 and 7 d), many tubules in the cortex showed pimonidazole uptake, indicating that these tubules were in a hypoxic condition. Treatment with an ARB, olmesartan, decreased pimonidazole uptake in the cortex of remnant kidneys at both time points (4 and 7 d), indicating that hypoxia of the tubulointerstitium may be mediated at least in part by activation of RAS. (c) In the extended phase (2 wk) of RK, rats showed sustained adduction of pimonidazole. (d) A high-magnification picture (×400) of sham animals showed the normal structure of perfused postglomerular capillary networks surrounded by tubules negative for pimonidazole. (e) In contrast, a high-magnification picture of the RK group showed pimonidazole adduction, indicating localized hypoxia.

To confirm the development of hypoxia in the early phase, we investigated expression levels of HIF-1α protein (Figure 3a). No expression of HIF-1α was detectable in the cortex in the sham group. In contrast, increased HIF-1α expression in the cortex was observed in 7d RK animals, which was consistent with the results of the pimonidazole uptake studies. RT-PCR analysis of a series of hypoxia-responsive genes also supported the presence of hypoxia in the kidney in the early phase. EPO, GLUT-1, and VEGF were markedly increased at this time point in the remnant kidneys, and ARB attenuated these changes (Figure 3b).

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Upregulation of hypoxia-responsive proteins in remnant kidneys. (a) Imunoprecipitation of HIF-1α using cortical tissues of sham and remnant kidney rats. HIF-1α was undetectable in sham kidneys, but was increased in remnant kidneys. (b) Transcription of hypoxia-responsive genes. Quantitative RT-PCR of the renal cortex of sham and remnant kidneys showed that all genes, including EPO, GLUT-1, and VEGF, were increased in remnant kidneys. Olmesartan-treated animals showed a decrease in all hypoxia-responsive genes. A, P < 0.05 versus sham; B, P < 0.05 versus RK.

Tubulointerstitial Damage after Tubular Hypoxia

To evaluate tubulointerstitial injury in detail, vimentin was employed as markers of tubular damage. α-SMA was employed to detect interstitial myofibroblasts, which are associated with interstitial damage and fibrosis. No difference between the sham and early remnant groups was seen (Figure 1, c, d, g, and h). In contrast, an increase in the number of vimentin-positive tubular cells as well as in α-SMA expression was seen in the extended phase (Table 2). These findings indicated that hypoxia during the early study period (within the first week) was unlikely to have been the result of tubulointerstitial damage.

Association of Hypoxia with Decreased Perfusion of the Peritubular Capillary Beds in the Early Phase

Because injected lectin binds to perfused endothelial cells under physiologic conditions, this method allows evaluation of both the amount of and morphologic changes in functioning postglomerular peritubular capillaries. The number of peritubular capillaries per 100 tubules and rarefaction index in 4d RK and 7d RK did not differ from that in the sham rats (Table 3). In contrast, the number of peritubular capillaries in the extended RK clearly decreased, to 137.8 ± 12.5 per 100 tubules, with rarefaction of 12 ± 3.7% (P < 0.05 versus sham). On this basis, hypoxia in the early phase could not be explained by any structural loss of peritubular capillary beds, in contrast to the extended phase, when histologic loss of peritubular capillaries was established. Notwithstanding this, significant morphologic changes in peritubular capillaries in the early stage were observed. In normal kidneys, peritubular capillaries are elliptical, circular, or triangular in cross-section, which preserves the patency of the lumina (Figure 4a). In contrast, peritubular capillaries in remnant kidney animals showed a distorted outline with relatively narrow capillary lumina (Figure 4b). Analysis of cross-sectional capillaries showed that the mean of capillary lumina area in remnant kidney animals was significantly lower than that of the control rats (Table 3). The histogram demonstrated that remnant kidney animals harbored abundant narrow capillaries (Figure 4d). Double immunostaining analysis using pimonidazole and lectin showed co-localization of narrow capillaries and hypoxic tubules (Figure 2e). This result was supported by correlation analysis (Figure 4e). Furthermore, ARB treatment preserved the structural integrity of postglomerular capillaries as well as luminal patency (Figure 4c and Table 3). These data suggested that the abnormality in peritubular capillaries might have been mediated at least in part by the activation of RAS.

Figure4
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 4. Change in pattern of postglomerular peritubular capillaries in remnant kidneys. Immunohistochemical studies were conducted on binding of injected lectin to endothelial cells of functioning capillaries. (a) In sham-operated animals, peritubular capillaries were arranged in a regular pattern with patent capillary lumina. (b) In early remnant kidneys (RK) (representative picture from 4d RK), most capillary lumina were distorted and had relatively narrow lumens. (c) ARB treatment restored the normal capillary morphology (representative picture from 7d RK+ARB). (d) Histogram of luminal area demonstrated that remnant kidneys harbored more narrow peritubular capillaries. Treatment with ARB prevented this change. (e) Correlation between mean capillary luminal area and pimonidazole score in each animal showed that narrowing of capillaries correlated with hypoxia.

View this table:
  • View inline
  • View popup

Table 3. Analysis of the vasculature in the early phase

Decreased Tissue Perfusion in Remnant Kidneys Was Observed by Administration of Hoechst 33342

When injected, the nuclear dye Hoechst 33342 rapidly diffuses from capillaries and is taken up by nuclei of the surrounding tissues. The nuclear fluorescence signals of Hoechst 33342 in a short perfusion time thus indirectly represent tissue perfusion states, which are determined by a number of factors, including capillary density, capillary permeability, and total blood flow of capillary networks. Uptake of Hoechst 33342 in glomeruli appeared to be higher than that of tubules in both nephrectomized and sham rats. The remnant kidney groups showed less and weaker nuclear fluorescence signals in the tubulointerstitial area compared with the control animals, further suggesting the poor tissue perfusion in this area (Figure 5, a and b; Table 3). Again, ARB treatment restored fluorescence signals of nuclei in tubular cells (Figure 5c; Table 3), indicating the role of RAS activation in the poor perfusion of peritubular capillaries.

Figure5
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 5. Tissue perfusion studies with Hoechest 33342 dye. Tissue perfusion status was assessed by injection of Hoechest 33342 dye exactly 30 s before removal of the kidney. In sham animals, nuclear fluorescence was intense in every area (a), whereas nuclear fluorescence signals in the RK group were distinctly decreased in the tubulointerstitial area (b). Treatment with ARB increased nuclear fluorescence (c), indicating that ARB restored net perfusion in remnant kidneys. Semiquantitative measurement of nuclear luminosity supported these results (Table 3).

Endothelial Cell Proliferation Occurred in Hypoxic Areas

An increase was seen in the number of PCNA-positive endothelial cells at day 7 after nephron loss (Figure 6, b and f). In contrast, PCNA-positive endothelial cells were hardly detected in the control (61.7 ± 14.7 versus 3 ± 2 per 1000 visualized capillary lumina; P < 0.05) (Figure 6, a and f). The number of PCNA-positive endothelial cells in the extended phase was slightly decreased to 51.5 ± 7.7 per 1000 visualized capillary lumina, although this value was still higher than that in the sham-operated animals (Figure 6f). ARB significantly decreased PCNA-positive endothelial cells at Day 7 of nephron ablation to 18.0 ± 3 per 1000 visualized capillary lumina (P < 0.05 versus 7d RK) (Figure 6, c and f). Triple immunostaining with lectin, pimonidazole, and PCNA indicated that endothelial proliferation occurred in the hypoxic area (Figure 6, d, e, and g). These findings suggested that endothelial proliferation may be one path to neoangiogenesis as a response to hypoxic stimuli.

Figure6
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 6. Hypoxia-induced endothelial proliferation. Double-staining with lectin (brown) and proliferative cell nuclear antigen (PCNA) (red) showed that endothelial proliferation was increased in remnant kidneys around day 7. (a) In sham animals, endothelial proliferation was rarely detected. (b) PCNA-positive endothelial cells were markedly increased in the 7d RK group. (c and f) ARB treatment decreased PCNA-positive endothelial cells at this time point. (d and e) Triple staining with lectin (brown), PCNA (red), and pimonidazole (gray) of 7d RK animals showed that endothelial proliferation in remnant kidneys was related to hypoxia and capillary pattern changes (representative pictures were taken from the same slide). In the hypoxic area of RK rats, tubules were pimonidazole-positive with distorted peritubular capillaries and expression of PCNA in capillary endothelium (e), while PCNA-positive endothelial cells were rarely seen in the nonhypoxic area, and tubules were accompanied by capillaries with preserved morphology. (g) The percentage of PCNA-positive endothelial cells per capillary lumina in nonhypoxic areas (pimonidazole score 0 or 1) was significantly lower than that in hypoxic areas (pimonidazole score >1). A, P < 0.05 versus sham; B, P < 0.05 versus RK; C, P < 0.05

Discussion

This current study demonstrates for the first time that perfusion is decreased in peritubular capillaries in the early phase of remnant kidney models, and that this decrease is associated with hypoxia in the tubulointerstitium. The hypoxic milieu in the tubulointerstitium precedes any pathologic changes in the corresponding region, suggesting a pathogenic role of ischemia at early time points.

We intended to perform this study at the early phase after nephron loss at an equivalent time point to that used in the landmark study of Hostetter and Brenner (1), when tubulointerstitial injury is negligible despite significant changes in renal hemodynamics. On this basis, our results were accompanied by glomerular hyperfiltration but were unlikely to be the result of tubulointerstitial damage. Increased cellular adduction of pimonidazole in remnant kidney tubules suggested that these tubular cells were hypoxic. The mechanism of cellular adduction of pimonidazole specifically depends on a hypoxia-induced redox state, and previous studies have demonstrated a good correlation between adduction and tissue O2 tension (31). However, to exclude the possibility that hypertrophic tubules might adduct pimonidazole without hypoxia via unidentified mechanisms, we measured HIF-1α expression.

HIF-1α is the master hypoxia response regulator, the amount of which is determined by oxygen-dependent degradation (32). Rosenberger et al. (33) found no detectable expression of HIF-1α in the normal kidney cortex. Here, we demonstrated an increased amount of this protein in the renal cortex in remnant kidneys, confirming that the remnant kidney milieu was indeed hypoxic. We also measured changes in mRNA levels of hypoxia-responsive genes, including EPO, GLUT-1, and VEGF. All these genes contain hypoxia-response elements (HRE) in their cis-regulatory promoter regions (30) and increase their transcription in the presence of hypoxia. Although the possibility of non-hypoxic transcriptional regulation of HIF-1 cannot be excluded (34), the upregulation of HIF and these hypoxia-responsive genes, together with the results using a hypoxia marker and the evaluation of tissue perfusion status, all point to the establishment of local hypoxia in our studies.

Previous studies suggest that kidney injury in the early phase is dependent on hemodynamic changes, whereas tubulointerstitial damage in the late phase is mediated by massive proteinuria (35). Development of tubulointerstitial hypoxia in the very early phase suggests its possible pathogenic role in tubulointerstitial injury at this stage. Basile et al. (22) reported that kidneys did not fully recover after severe ischemic acute renal failure and that this lack of recovery was associated with the loss of peritubular capillaries and an increase in tubular pimonidazole adduction. Suga et al. (23) also showed increased adduction of pimonidazole in a hypokalemic nephropathy model with tubulointerstitial injury. Using BOLD MRI, Ries et al. (36) reported hypoxia in the renal cortex of diabetic rats in the early hyperfiltration phase. Recent studies by Johnson et al. (37) demonstrated that chronic systemic hypoxia causes renal interstitial damage. Previous work by Truong group (38) and our group (17) on kidneys subject to renal artery stenosis also supported a role of hypoxia in tubulointerstitial injury. In contrast to these previous and our present findings, Priyadarshi et al. (39) performed direct measurement of tissue oxygen tensions by microelectrode in the late phase of a remnant kidney model and reported a relative increase in tissue oxygen tension. The reason for this discrepancy is unclear, but the microelectrode method may have detected regional hyperoxia. An alternative explanation may be the difference in study’s time point.

The finding of tubular hypoxia in the early phase stimulated us to investigate the responsible mechanisms. Intravenous injection of biotinylated lectin under physiologic conditions, which allows evaluation of the amount and structure of functioning capillaries (24), showed no changes in the number of capillaries per tubule or vascular rarefaction at our early time points, but it did reveal striking morphologic changes in the capillary network pattern. Many peritubular capillaries in remnant kidney animals were distorted and collapsed, showing a streak-like appearance. Quantitative analysis showed that remnant kidney harbored a large number of narrow peritubular capillaries. Furthermore, correlation analysis showed that the degree of capillary narrowing was related to that of pimonidazole adduction. Of interest, the narrowing of peritubular capillaries had been previously reported in several human diseases (6,40⇓). It should be emphasized that the flow in individual capillary beds is dynamic but under the tight regulation of an active feedback system and that the diameter of a vessel is the primary determinant of its flow (41); we therefore speculate that these peritubular capillary changes may be related to poor tissue perfusion, leading to hypoxia. A second experiment provided indirect support for this speculation; on measurement of tissue perfusion by injection of nuclear dye, a well-established method in oncology research (25,27,28,42⇓⇓⇓), remnant kidney animals showed a decrease in tubulointerstitial nuclear fluorescence signals.

Neoangiogenesis is a common response to chronic hypoxia. Kang et al. (11) and Pillebout et al. (43) reported transient endothelial proliferation, which may be considered as a component of neoangiogenesis, in a remnant kidney model while Ohashi et al. (7) observed this phenomenon in a unilateral ureteral obstruction (UUO) model. A recent study by Rosenberger et al. (44) suggested that hypoxia might stimulate peritubular capillary endothelial proliferation. Our results also revealed that endothelial proliferation co-localized with areas of hypoxia, suggesting that endothelial proliferation (in this model) might be another response to hypoxia.

Activation of RAS is the earliest humoral response after nephron loss (45), and several clinical studies have shown that angiotensin-converting enzyme inhibitors (ACEI) and ARB effectively attenuate the progression of kidney disease (46,47⇓). Our results revealed that ARB attenuated pimonidazole adduction in tubular cells and preserved peritubular capillary network structure. The expression of hypoxia-responsive genes was also decreased in ARB-treated animals, suggesting that tubulointerstitial hypoxia in remnant kidneys is mediated by the activation of RAS, possibly via their vasoconstrictive effects on efferent arterioles. This speculation is supported by recent findings by Norman et al. (48), who showed that treatment with ACEI and ARB increased cortical tissue O2 tension and proposed that this might be another renoprotective role of these drugs. In addition, Fujimoto et al. (49) reported that chronic angiotensin infusion resulted in a decrease in peritubular blood flow, which was accompanied by adduction of pimonidazole. Taken together, these and the present results emphasize the role of RAS activation in the disturbance of tubulointerstitial microcirculation and subsequent hypoxia. Moreover, they support the notion that improvement of cortical tissue oxygenation might be another renoprotective property of ARB and ACEI.

In conclusion, we have demonstrated that the hypoxic milieu in the tubulointerstitium precedes any pathologic change in the corresponding region, suggesting a pathogenic role of ischemia at early time points. Our results suggested that perfusion was decreased in peritubular capillaries in association with hypoxia in the tubulointerstitium in the early phase of remnant kidney models, and these changes may be mediated by the activation of RAS.

Acknowledgments

We acknowledge research grants from the Japanese Ministry of Health, Labor and Welfare, NOVARTIS Foundation (Japan) for the Promotion of Science, and Kanae Foundation for Life and Socio-Medical Science (Japan). We thank Dr. Ryoji Sassa (Okazaki Kita Clinic, Nagoya, Japan), Dr. Taichi Ezaki (Tokyo Women’s Medical University, School of Medicine, Tokyo, Japan), and Dr. Kriang Tungsanga (Division of Nephrology, Chulalongkorn University Hospital, Bangkok, Thailand).

  • © 2004 American Society of Nephrology

References

  1. ↵
    Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: a potential adverse response to renal abrasion. Am J Physiol 241: F85–F93, 1981
  2. ↵
    Nath KA: Tubulointerstitial changes as a major determinant in progression of renal damage. Am J Kidney Dis 1: 1–17, 1992
    OpenUrl
  3. ↵
    Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448–1456, 1998
    OpenUrlCrossRefPubMed
  4. ↵
    Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495–2508, 1996
    OpenUrlAbstract
  5. ↵
    Fine LG, Bandyopadhay D, Norman JT: Is there a common mechanism for the progression of different types of renal disease other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 57 [Suppl 75]: S22–S26, 2000
  6. ↵
    Bohle A, Mackensen-Haen S, Wehrmann M: Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19: 191–195, 1996
    OpenUrlCrossRefPubMed
  7. ↵
    Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N: Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 13: 1795–1805, 2002
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Ohashi R, Kitamura H, Yamanaka N: Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 11: 47–56, 2000
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Nangaku M, Yamada K, Gariepy CE, Miyata T, Inagi R, Kurokawa K, Yanagisawa M, Fujita T, Johnson RJ: ET(B) receptor protects the tubulointerstitium in experimental thrombotic microangiopathy. Kidney Int 62: 922–928, 2002
    OpenUrlCrossRefPubMed
  10. ↵
    Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ: Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37: 601–611, 2001
    OpenUrlPubMed
  11. ↵
    Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434–1447, 2001
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Norman JT, Clark IM, Garcia P: Hypoxia promotes fibrogenesis in human renal fibroblast. Kidney Int 58: 2351–2366, 2000
    OpenUrlCrossRefPubMed
  13. ↵
    Sodhi CP, Phadke SA, Batlle D, Sahai A: Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: Role of osteopontin. Am J Physiol Renal Physiol 280: F667–F674, 2001
    OpenUrlPubMed
  14. ↵
    Orphanides C, Fine LG, Norman JT: Hypoxia stimulates proximal tubular cell matrix production via TGF-β1 independent mechanism. Kidney Int 52: 637–647, 1997
    OpenUrlCrossRefPubMed
  15. ↵
    Tanaka T, Hanafusa N, Ingelfinger JR, Ohse T, Fujita T, Nangaku M: Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun 309: 222–231, 2003
    OpenUrlCrossRefPubMed
  16. ↵
    Tanaka T, Miyata T, Inagi R, Kurokawa K, Adler S, Fujita T, Nangaku M: Hypoxia-induced apoptosis in cultured glomerular endothelial cells: Involvement of mitochondrial pathways. Kidney Int 64: 2020–2032, 2003
    OpenUrlCrossRefPubMed
  17. ↵
    Manotham K. Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M: Transdifferentiation of cultured tubular cell induced by hypoxia. Kidney Int 65: 871–880, 2004
    OpenUrlCrossRefPubMed
  18. ↵
    Johnson TS, Griffin M, Thomas GL, Skill J, Cox A, Yang B, Nicholas B, Birckbichler PJ, Muchaneta-Kubara C, El Nahas AM: The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99: 2950–2960, 1997
    OpenUrlCrossRefPubMed
  19. ↵
    Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49: 666–678, 1996
    OpenUrlCrossRefPubMed
  20. ↵
    Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T: Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42: 31–38, 2003
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Arteel GE, Iimuro Y, Yin M, Raleigh JA, Thurman RG: Chronic enteral ethanol treatment causes hypoxia in rat liver tissue. Hepatology 25: 920–926, 1997
    OpenUrlCrossRefPubMed
  22. ↵
    Basile DP, Donohoe DL, Roethe K, Mattson DL: Chronic renal hypoxia after ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284: F338–F348, 2002
  23. ↵
    Suga SI, Phillips MI, Ray PE, Raleigh JA, Vio CP, Kim Y, Mazzali M, Gordon KL, Hughes J, Johnson RJ: Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. Am J Physiol Renal Physiol 281: F620–F629, 2001.
    OpenUrlPubMed
  24. ↵
    Ezaki T, Baluk P, Thurston G, La Barbara A, Woo C, McDonald DM: Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am J Pathol 158: 2043–2055, 2001
    OpenUrlCrossRefPubMed
  25. ↵
    Busch TM, Wileyto EP, Emanuele MJ, Del Piero F, Marconato L, Glatstein E, Koch CJ: Photodynamic therapy creates fluence rate-dependent gradients in intratumoral spatial distribution of oxygen. Cancer Res 62: 7273–7279, 2002
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Nangaku M, Quigg RJ, Shankland SJ, Okada N, Johnson RJ, Couser WG: Over expression of Crry protects mesangial cells from complement-mediated injury. J Am Soc Nephrol 8: 223–233, 1997
    OpenUrlAbstract
  27. ↵
    Kostourou V, Robinson SP, Whitley GS, Griffiths JR: Effects of over expression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer Res 63: 4960–4966, 2003
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS: High-frequency doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 62: 6371–6375, 2002
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Freeburg PB, Robert B, St John PL, Abrahamson DR: Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development. J Am Soc Nephrol 14: 927–938, 2003
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M: Induction of renoprotective gene expression by cobalt ameliorate ischemic injury of the kidney in rats. J Am Soc Nephrol 14: 1825–1832, 2003
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Arteel GE, Thurman RG, Raleigh JA: Reductive metabolism of hypoxic marker pimonidazole is regulate by oxygentension, independent of pyridine redox state. Eur J Biochem 253: 743–750, 1998
    OpenUrlPubMed
  32. ↵
    Safran M, Kaelin WG: HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest 111: 779–783, 2003
    OpenUrlCrossRefPubMed
  33. ↵
    Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13: 1721–1732, 2002
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Richard DE, Berra E, Pouysségur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 in vascular smooth muscle cells. J Biol Chem 275: 26765–26771, 2000
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Nangaku M, Pippin J, Couser WG: C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 13: 928–936, 2002
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, Combe C, Moonen CW, Grenier N: Renal diffusion and BOLD MRI in experimental diabetic nephropathy. J Magn Reso Imaging 17: 104–113, 2003
  37. ↵
    Mazzali M, Jefferson JA, Ni Z, Vaziri ND, Johnson RJ: Microvascular and interstititial injury associated with Chronic hypoxia induced hypertension. Kidney Int 16: 2088–2093, 2003
  38. ↵
    Truong LD, Farhood A, Tasby J, Gillum D: Experimental chronic renal ischemia: Morphological and immunohistochemical studies. Kidney Int 41: 1676–1689, 1992
    OpenUrlCrossRefPubMed
  39. ↵
    Priyadarshi A, Periyasamy S, Burke TJ, Britton SL, Malhotra D, Shapiro JI: Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat. Kidney Int 61: 542–546, 2002
    OpenUrlCrossRefPubMed
  40. ↵
    Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD: Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum Pathol 31: 1491–1497, 2000
    OpenUrlCrossRefPubMed
  41. ↵
    Pries AR, Reglin B, Secomb TW: Structural response of microcirculatory networks to changes in demand: information transfer by shear stress. Am J Physiol Heart Circ Physiol 284: H2204–H2212, 2003
    OpenUrlCrossRefPubMed
  42. ↵
    Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS, Coomber BL: Heterogenous vascular dependence of tumor cell population. Am J Pathol 158: 1325–1334, 2003
    OpenUrl
  43. ↵
    Pillebout E, Burtin M, Yuan HT, Briand P, Woolf AS, Friedlander G, Terzi F: Proliferation and remodeling of peritubular microcirculation after nephron reduction associate with the progression of renal lesions. Am J Pathol 159: 547–560, 2001
    OpenUrlCrossRefPubMed
  44. ↵
    Rosenberger C, Griethe W, Gruber G, Wiesener M, Frei U, Bachmann S, Eckardt KU: Cellular responses to hypoxia after renal segmental infarction. Kidney Int 64: 874–886, 2003
    OpenUrlCrossRefPubMed
  45. ↵
    Rosenberg ME, Correa-Rotter R, Inagami T, Kren SM, Hostetter TH: Glomerular renin synthesis and storage in the remnant kidney in the rat. Kidney Int 40: 677–683, 1991
    OpenUrlCrossRefPubMed
  46. ↵
    Gruppo Italiano di Studi Epidemiologici in Nepfrologia (GISEN): Randomized placebo-control trial of effect of ramipril in glomerular filtration rate and risk of terminal renal failure in proteinuric non-diabetic nephropathy. Lancet 349: 1857–1863, 1997
    OpenUrlCrossRefPubMed
  47. ↵
    Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular out come in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861–869, 2001
    OpenUrlCrossRefPubMed
  48. ↵
    Norman JT, Stidwill R, Singer M, Fine LG: Angiotensin II blockage augment renal cortical microvascular pO2 indicating a novel potential renoprotective action. Nephron Physiol 94: 39–46, 2003
  49. ↵
    Fujimoto S, Satoh M, Ozeki M, Kobayashi S, Haruna Y, Arakawa S, Horike H, Sasaki T, Kashihara N: A long acting calcium channel blocker, azelnidipine, ameliorates angiotensin II induced renal damage in rats [Abstract]. J Am Soc Nephrol 10: 609A, 2003
    OpenUrl
View Abstract
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 15 (5)
Journal of the American Society of Nephrology
Vol. 15, Issue 5
1 May 2004
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Evidence of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evidence of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model
Krissanapong Manotham, Tetsuhiro Tanaka, Makiko Matsumoto, Takamoto Ohse, Toshio Miyata, Reiko Inagi, Kiyoshi Kurokawa, Toshiro Fujita, Masaomi Nangaku
JASN May 2004, 15 (5) 1277-1288; DOI: 10.1097/01.ASN.0000125614.35046.10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Evidence of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model
Krissanapong Manotham, Tetsuhiro Tanaka, Makiko Matsumoto, Takamoto Ohse, Toshio Miyata, Reiko Inagi, Kiyoshi Kurokawa, Toshiro Fujita, Masaomi Nangaku
JASN May 2004, 15 (5) 1277-1288; DOI: 10.1097/01.ASN.0000125614.35046.10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Slowly Progressive, Angiotensin II–Independent Glomerulosclerosis in Human (Pro)renin Receptor–Transgenic Rats
  • Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats
  • Evidence for the Role of Reactive Nitrogen Species in Polymicrobial Sepsis-Induced Renal Peritubular Capillary Dysfunction and Tubular Injury
Show more Pathophysiology of Renal Disease and Progression

Cited By...

  • Hypoxia-Inducible Factor and Oxygen Biology in the Kidney
  • Hepatocyte Growth Factor Inhibits Renal Angiotensin II Expression in 5/6 Nephrectomized Rats
  • Hypoxia-mediated regulation of mitochondrial transcription factors: Implications for hypertensive renal physiology
  • Initiation and Progression of Chronic Kidney Disease: Can We Definitively Test the Chronic Hypoxia Hypothesis?
  • Myeloid Cell-Derived Hypoxia-Inducible Factor Attenuates Inflammation in Unilateral Ureteral Obstruction-Induced Kidney Injury
  • Aberrant Tubuloglomerular Feedback and HIF-1{alpha} Confer Resistance to Ischemia after Subtotal Nephrectomy
  • SOX9 Protein Induces a Chondrogenic Phenotype of Mesangial Cells and Contributes to Advanced Diabetic Nephropathy
  • Chronic Kidney Disease: An Inherent Risk Factor for Acute Kidney Injury?
  • HIF in Kidney Disease and Development
  • Peritubular Ischemia Contributes More to Tubular Damage than Proteinuria in Immune-Mediated Glomerulonephritis
  • Biliverdin Reductase Mediates Hypoxia-Induced EMT via PI3-Kinase and Akt
  • Effects of Calcium Channel Blockade on Angiotensin II-Induced Peritubular Ischemia in Rats
  • Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure
  • Renoprotective Properties of Angiotensin Receptor Blockers beyond Blood Pressure Lowering
  • Protection of Endothelial Cells by Dextran Sulfate in Rats with Thrombotic Microangiopathy
  • Immunoregulation in Urinary Tract Inflammation--A Role of Tamm-Horsfall Glycoprotein: Tamm-Horsfall Glycoprotein Links Innate Immune Cell Activation with Adaptive Immunity via a Toll-Like Receptor-4-Dependent Mechanism. J Clin Invest 115: 468-475, 2005
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire